Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Pounce™ Thrombectomy System Retrospective Registry
for
Peripheral Arterial Disease, Acute Limb Ischemia
Location: Cleveland OH, Greenville SC, Nashville TN, Peoria IL,
Sponsor: SurModics, Inc.
Sex: All
Age: 18+
Code: NCT05868161
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase3, Recruiting
ViewFlex X ICE First-in-Human Study
for
Cardiac Arrhythmias
Location: New York NY, Philadelphia PA, Charleston SC,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06772493
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CGM for Management of Type 2 Diabetes in Pregnancy
for
Type 2 Diabetes Mellitus (T2DM), Pregnancy
Location: Philadelphia PA, Chapel Hill NC, Greenville SC,
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 18 - 50
Code: NCT06628453
Recruiting
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Durham NC, Charleston SC, St Louis MO, Houston TX
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05793151
Recruiting
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
for
Binge-Eating Disorder
Location: Boston MA, Cromwell CT, Mount Kisco NY, New York NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT06413433
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
for
Overactive Bladder (OAB), Urinary Urgency,
Location: Washington D.C. DC, Charleston SC, Winston-Salem NC,
Sponsor: Medstar Health Research Institute
Sex: Female
Age: 22+
Code: NCT06797245
Recruiting
STRIDE Biorepository
for
Anemia, Sickle Cell
Location: Bronx NY, New York NY, Brooklyn NY, Hackensack NJ,
Sponsor: Emory University
Sex: All
Age: 15 - 40
Code: NCT02843347
Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Providence RI, New Haven CT, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Halifax, Shirley NY, New York NY, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT02660645
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,